scispace - formally typeset
M

Marta Gwinn

Researcher at Centers for Disease Control and Prevention

Publications -  142
Citations -  10917

Marta Gwinn is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Public health. The author has an hindex of 53, co-authored 135 publications receiving 10161 citations.

Papers
More filters
Journal ArticleDOI

HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States.

TL;DR: Investigation of HIV incidence and trends in incidence among men who have sex with men (MSM) and heterosexual men and women at clinics for sexually transmitted diseases (STDs) by using a recently developed serologic testing algorithm found unchanged rates of new HIV infections among MSM and heterosexual patients attending these clinics remained unchanged during the time studied.
Journal ArticleDOI

GAPscreener: An automatic tool for screening human genetic association literature in PubMed using the support vector machine technique

TL;DR: GAPscreener is the first free SVM-based application available for screening the human genetic association literature in PubMed with high recall and specificity, and is a practical, stand-alone application.
Journal ArticleDOI

Steroid 5-α-Reductase Type 2 (SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review

TL;DR: The authors found that prostate cancer was not associated with V89L (L allele vs. V allele: odds ratio = 0.99, 95% confidence interval: 0.94, 1.05) and was probably notassociated with A49T (T allele vs., A allele:dds ratio = 1.10, 95%) and could have been distorted by spectrum-of-disease bias, convenience sampling of cases and controls, genotype misclassification, and/or confounding
Journal ArticleDOI

Integrating Advanced Molecular Technologies into Public Health

TL;DR: The Advanced Molecular Detection (AMD) initiative has allowed the Centers for Disease Control and Prevention to provide leadership and coordination in integrating new technologies into routine practice throughout the U.S. public health laboratory system.